References

  • www.clinicaltmssociety.orgbaytms.com
  • www.siliconvalleytms.com
  • www.lenoxhilltms.com
  • www.mindfulhealthsolutions.com
  • www.northerncaliforniatms.com
  • www.therapeuticsolutionspc.com
  • www.wellmindcenter.com
  • www.neurostar.com
  • www.neuronetics.com
  • www.brainsway.com
  • www.tmsyou.org
  • American Psychiatric Association (2010) (eds: Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, Van Rhoads RS).  Practice Guidelines for the Treatment of Patients with Major Depressive Disorder, 3rd Edition.
  • http://www.psychiatryonline.com/pracGuide/pracGuideTopic_7.aspx Avery DH, Isenberg KE, Sampson SM, et al. Transcranial magnetic stimulation in the acute treatment of major depression: clinical response in an open-label extension trial. J Clin Psychiatry. 2008;6(3):441-451
  • Blue Cross Blue Shield Association (BCBSA). Technology Evaluation Center (TEC). Transcranial magnetic stimulation for depression. TEC Assessment Program. Chicago, IL:BCBSA. 2009:24(5).
  • http://www.bcbs.com/blueresources/TEC/press/transcranial-magnetic.html. Accessed 04/28/2011. CIGNA Medical Policy – Transcranial Magnetic Stimulation – updated 01/15/2011. Chen R. Repetitive transcranial magnetic stimulation as treatment for depression in Parkinson’s disease. Movement Disorders 2010;25(14):2272- 2273.
  • Carpenter LL, et al.  (2012). Depress Anxiety, 29(7):587-596.
  • Croarkin PE, Wall CA, McClintock SM, et al. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. Journal of ECT 2010;26(4):323-329.
  • Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and metaanalysis. J Psychiatry Neurosci. 2005;30(2):83-90.
  • Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for major depressive disorder. A review. Can J Psychiatry. 2008;53(9):555-566.
  • Demitrack MA, Thase ME. (2009). Psychopharmacol  Bull, 42(2):5-38.
  • Fitzgerald PB, Hoy K, McQueen S, et al. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsycholpharmacology. 2009;34(5):1255-1262.
  • Gaynes BN, et. al. Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults. Comparative Effectiveness Review No. 33. AHRQ Publication No. 11-EHC056-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2011. Available at: http://www.effectivehealthcare.ahrq.gov/reports/final.cfm.
  • George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder. A shamcontrolled randomized trial. Arch Gen Psychiatry. 2010;60(5)507-516.
  • George MS. Transcranial magnetic stimulation for the treatment of depression. Expert Rev. Neurother 2010;10(11):1761-1772. Glenberg AJ, Freeman MP, Markowitz JC, et al. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. American Psychiatric Association October 2010.
  • http://www.psychiatryonline.com/pracGuide/PracticePDFs/PG_Depression3rdEd.pdf Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand. 2007;116:165-73.
  • Hayes Inc. Evaluating the efficacy of transcranial magnetic stimulation to treat major depression. Hayes Overview. Lansdale, PA; Hayes, May 25, 2010.
  • Herbsman T, Avery D. Ramsey D, et al. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry. 2009;66(5):509-515.
  • Holtzheimer PE, McDonald WM, Mutfi M, et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depression and Anxiety 2010;27:960-963.
  • ICD-10 classifications of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organization. www.who.int/classifications/icd/en/bluebook.pdf. Accessed March 12, 2013.
  • Janicak PG, et al. (2008). J Clin Psychiatry, 69(2):222-232.
  • Janicak PG, et al. (2010). Brain Stimulation, 3(4):187-199.
  • Kessler, RC et al. (2003). JAMA, 289:3095-3105.
  • Lam RW, Chan P, Wilkins-Ho M, Yatham LN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry. 2008;53:621-631.
  • The Institute of Clinical and Economic Review (2011). Nonpharmacologic Interventions for Treatment-Resistant Depression: Supplementary Data and Analyses to the Comparative Effectiveness Review of the Agency for Healthcare Research and Quality. Boston, MA: http://cepac.icer-review.org/wpcontent/ uploads/2012/01/Final-Report-TRD_FINAL1.pdf
  • Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34:522-534.
  • Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2008;11(1):131-147.
  • Mark DH, Aronson N, Ziegler KM, et al. Transcranial Magnetic Stimulation for Depression. TEC Assessment Program October 2009;24(5).
  • Martin JL, Barbanoj MJ, Schlaepfer TE, et al. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry. 2003;182:480-491.
  • National Institute of Mental Health. US Department of Health and Human Services. Depression. www.nimh.nih.gov/health/publications/depression/complete-index.shtml. Accessed April 24, 2013.
  • O'Reardon JP, Solvason HB, Janicak PG et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208-1216.
  • Other Medicare contractors’ LCDs Rodriguez-Martin JL, Barbanoj JM, Schlaepfer TE, Clos SSC, Pérez V, Kulisevsky J, Gironelli A. Transcranial magnetic stimulation for treating depression. Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD003493. DOI:10.1002/14651858.CD003493. Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. http://www.thecochranelibrary.com. Accessed 04/28/2011.
  • Rosenberg O, Zangen A, Stryjer R, et al. Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimulation 2010; 3:211-217.
  • Rush AJ, Trivedi MY, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905-1917.
  • Schutter DJ. Antidepressant efficacy of high frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham controlled designs: a meta-analysis. Psychol Med. 2009;39:65-75.
  • The Regance Group. Medical Policy -Transcranial Magnetic Stimulation as a Treatment of Depression and Other Disorders. Policy No. 17. Updated 03/01/2011.
  • Uwe H, Padberg F, Unger J, Spitzer M, and Schonfeldt-Lecuona S. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry. 20001;50:58-61.
  • UnitedHealthCare Medical Policy 2011T0536B effective January 1, 2011. Transcranial Magnetic Stimulation. https://www.unitedhealthcareonline.com. Accessed 04/28/2011. U.S. Food and Drug Administration (2007) Neurological Devices Panel of the Medical Devices Advisory Committee. January 26, 2007.
  • World Health Organization. Depression Fact Sheet. http://www.who.int/mediacentre/factsheets/fs369/en/index.html. Accessed February 27, 2013.
  • World Health Organization. The global burden of disease: 2004 update. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. Accessed March 12, 2013.
  • World Health Organization. World Health Report: 2001: Mental Health: New Understanding, New Hope. www.who.int/whr/2001/en/whr01_en.pdf. Accessed March 12, 2013.
  • FDA Executive Summary. http://www.fda.gov/AdvisoryCommittees/CommitteesMetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommitteee/NeurologicalDevices Panel/ucm124779.htm. Accessed 04/28/2011